SEARCH

SEARCH BY CITATION

References

  • Baba A., Lee E., Matsuda T., Kihara T. and Iwata H. (1978) Reversible inhibition of adenylate cyclase activity of rat brain caudate nucleus by oxidized glutathione. Biochem. Biophy. Res. Comm. 85, 12041210.
  • Bellomo G., Mirabelli F., DiMonte D., Richelmi P., Thor H., Orrenius C. and Orrenius S. (1987) Formation and reduction of glutathione-protein–mixed disulfides during oxidative stress. A study with isolated hepatocytes and menadione (2-methyl-1,4-napthoquinone). Biochem. Pharmacol. 36, 13131320.
  • Benard O. and Balasubramanian K. A. (1995) Effect of oxidized glutathione on intestinal mitochondria and brush border membrane. Int. J. Biochem. Cell Biol. 27, 589595.
  • Ben-Shachar D., Zuk R. and Glinka Y. (1997) Dopamine neurotoxicity: inhibition of mitochondrial respiration. J. Neurochem. 64, 718723.
  • Berman S. B. and Hastings T. G. (1999) Dopamine oxidation alters mitochondrial respiration and induces permeability transition in brain mitochondria: implications for Parkinson's disease. J. Neurochem. 73, 11271137.DOI: 10.1046/j.1471-4159.1999.0731127.x
  • Betarbet R., Sherer T. B., MacKenzie G., Garcia-Osuna M., Panov A. V. and Greenamyre J. T. (2000) Chronic systemic pesticide exposure reproduces features of Parkinson's disease. Nat. Neurosci. 3, 13011306.
  • Blin O., Desnuelle C., Rascol O., Borg M., Peyro Saint Paul H., Azulay J. P., Bille F., Figarella D., Coulom F. and Pellissier J. F. (1994) Mitochondrial respiratory failure in skeletal muscle from patients with Parkinson's disease and multiple system atrophy. J. Neurosci. 125, 95101.
  • Brigelius R., Lenzen R. and Sies H. (1982) Increase in hepatic mixed disulfide and glutathione disulfide levels elicited by paraquat. Biochem. Pharmacol. 31, 16371641.
  • Brigelius R., Muckel C., Akerboom T. P. M. and Sies H. (1983) Identification and quantification of glutathione in hepatic protein mixed disulfides and its relationship to glutathione disulfide. Biochem. Pharmacol. 32, 25292534.
  • Burns R. S., Chiueh C. C., Markey S. P., Ebert M. H., Jacobowitz D. M. and Kopin I. J. (1983) A primate model of parkinsonism: selective destruction of dopaminergic neurons in the pars compacta of the substantia nigra by N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine. Proc. Natl. Acad. Sci. USA 80, 45464550.
  • Chance B., Sies H. and Boveris A. (1979) Hydroperoxide metabolism in mammalian organs. Physiol. Rev. 59, 527605.
  • Clark J. B. and Nicklas W. J. (1970) Metabolism of rat brain mitochondria: preparation and characterization. J. Biol. Chem. 245, 47244731.
  • Cohen G. and Kesler N. (1999) Monoamine oxidase and mitochondrial respiration. J. Neurochem. 73, 23102315.
  • Cohen G., Farooqui R. and Kesler N. (1997) Parkinson disease: a new link between monoamine oxidase and mitochondrial electron flow. Proc. Natl. Acad. Sci. USA 94, 48904894.
  • Davis G. C., Williams A. C., Markey S. P., Ebert M. H., Caine E. D., Reichert C. M. and Kopin I. J. (1979) Chronic parkinsonism secondary to intravenous injection of meperidine analogues. Psychiatry Res. 1, 249254.
  • Ehrhart J. and Zeevalk G. D. (2001) Hydrogen peroxide removal and glutathione mixed disulfide formation during metabolic inhibition in mesencephalic cultures. J. Neurochem. 77, 14961507.DOI: 10.1046/j.1471-4159.2001.00355.x
  • Gilbert H. F. (1982) Biological disulfides: the third messenger? Modulation of phosphofructokinase activity by thiol/disulfide exchange. J. Biol. Chem. 257, 1208612091.
  • Gluck M. R., Kreuger M. J., Ramsay R. R., Sablin S. O., Singer T. E. and Nicklas W. J. (1994) Characterization of the inhibitory mechanism of 1-methyl-4-phenylpyridinium and 4-phenylpyridine analogs in inner membrane preparations. J. Biol. Chem. 269, 31673174.
  • Gravina S. A. and Mieyal J. J. (1993) Thioltransferase is a specific glutathionyl mixed disulfide oxidoreductase. Biochemistry 32, 33683376.
  • Griffith O. W. (1980) Determination of glutathione and glutathione disulfide using glutathione reductase and 2-vinylpyridine. Anal. Biochem. 106, 207212.
  • Gutman M., Mersmann H., Luthy J. and Singer T. P. (1970) Action of sulfhydryl inhibitors on different forms of the respiratory chain-linked reduced nicotinamide-adenine dinucleotide dehydrogenase. Biochemistry 9, 26782687.
  • Halliwell B. (1989) Oxidants and the central nervous system: some fundamental questions. Is oxidant damage relevant to Parkinson's disease, Alzheimer's disease, trauma or stroke? Acta Neurol. Scand. Suppl. 126, 2333.
  • Hauptmann N., Grimsby J., Shih J. C. and Cadenas E. (1996) The metabolism of tyramine by monoamine oxidase A/B causes oxidative damage to mitochondrial DNA. Arch. Biochem. Biophys. 335, 295304.DOI: 10.1006/abbi.1996.0510
  • Heikkila R. E., Hess A. and Duvoisin R. C. (1984) Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6 tetrahydropyridine in mice. Science 224, 14511453.
  • Helmuth L. (2000) Pesticide causes Parkinson's in rats. Science 290, 1068.
  • Hiranruengchok R. and Harris C. (1995) Formation of protein-glutathione mixed disulfides in the developing rat conceptus following diamide treatment in vitro. Teratology 52, 196204.
  • Hornykiewicz O. and Kish S. J. (1986) Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45, 1934.
  • Kristal B. S., Conway A. D., Brown A. M., Jain J. C., Ulluci P. A., Li S. W. and Burke W. J. (2001) Selective dopaminergic vulnerability: 3,4-dihydroxyphenylacetaldehyde targets mitochondria. Free Rad. Biol. Med. 30, 924931.
  • Lan J. and Jiang D. H. (1997) Desferrioxamine and vitamine E protect against iron and MPTP-induced neurodegenration in mice. J. Neural Transmission 104, 469481.
  • Langston J. W., Ballard P., Tetrud J. W. and Irwin I. (1983) Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science 219, 979980.
  • Lowry O. H., Rosebrough N. J., Farr A. L. and Randall R. J. (1951) Protein measurement with the folin phenol reagent. J. Biol. Chem. 193, 265275.
  • Mizuno Y., Ohta S., Tanaka M., Takamiya S., Suzuki K., Sato T., Oya H., Ozawa T. and Kagawa Y. (1989) Deficiencies in Complex I subunits of the respiratory chain in Parkinson's disease. Biochem. Biophys. Res. Commun. 163, 14501455.
  • Morikawa N. and Nakagawa-Hattori Ya, M. Y. (1996) Effect of dopamine, dimethoxphenylethylamine, papaverine and related compounds on mitochondrial respiration and complex I activity. J. Neurochem. 66, 11741181.
  • Olafsdottir K. and Reed D. J. (1988) Retention of oxidized glutathione by isolated rat liver mitochondria during hydroperoxide treatment. Biochim. Biophys. Acta 964, 377382.
  • Parker W. D., Boyson S. J. and Parks J. K. (1989) Abnormalities of the electron transport chain in idiopathic Parkinson's disease. Ann. Neurol. 26, 719733.
  • Przedborski S., Jackson-Lewis V., Muthane U., Jiang H., Ferreira M., Naini A. B. and Fahn S. (1993) Chronic levodopa administration alters cerebral mitochondrial respiratory chain activity. Ann. Neurol. 34, 715723.
  • Quio F., Xing K. and Lou M. F. (2000) Modulation of lens glycolytic pathway by thioltransferase. Exp. Eye Res. 70, 745753.
  • Ragan C. I., Wilson M. T., Darley-Usmar V. M. and Lowe P. N. (1987) Sub-fractionation of mitochondria and isolation of the proteins of oxidative phosphorylation. In: Mitochondria: A Practical Approach (Darley-UsmarV. M., RickwoodD. and WilsonM. T., eds), pp. 79112. Oxford: IRL Press.
  • Ravindranath V. and Reed D. J. (1990) Glutathione depletion and formation of glutathione-protein mixed disulfide following exposure of brain mitochondria to oxidative stress. Biochem. Biophys. Res. Comm. 169, 10751079.
  • Rokutan K., Johnston R. B. Jr and Kawai K. (1994) Oxidative stress induces S-thiolation of specific proteins in cultured gastric mucosal cells. Am. J. Physiol. 29, G247G254.
  • Schapira A. H., Cooper J. M., Dexter D., Jenner P., Clark J. B. and Marsden C. D. (1989) Mitochondrial complex I deficiency in Parkinson's disease. Lancet 1, 1269.
  • Schapira A. H., Cooper J. M., Dexter D., Clark J. B., Jenner P. and Marsden C. D. (1990) Complex I deficiency in Parkinson's disease. J. Neurochem. 54, 823827.
  • Seres T., Ravichandran V., Moriguchi T., Rokutan K., Thomas J. A. and Johnston Jr R. B. (1996) Protein S-thiolation and dethiolation during the respiratory burst in human monocytes. J. Immunol. 156, 19731980.
  • Shivakumar B. R., Kolluri S. V. R. and Ravindranath V. (1995) Glutathione and protein thiol homeostasis in brain during reperfusion after cerebral ischemia. J. Pharmacol. Exp. Ther. 274, 11671173.
  • Sims N. R., Anderson M. F., Hobbs L. M., Kong J. Y., Phillips S., Powell J. A. and Zaidan E. (2000) Impairment of brain mitochondrial function by hydrogen peroxide. Mol. Brain Res. 77, 176184.
  • Sinet P. M., Heikkila R. E. and Cohen G. (1980) Hydrogen peroxide formation by rat brain in vivo. J. Neurochem. 34, 14211428.
  • Spina M. B. and Cohen G. (1989) Dopamine turnover and glutathione oxidation: implications for Parkinson's disease. Proc. Natl. Acad. Sci. USA 86, 13981400.
  • Swerdlow R. H., Parks J. K., Miller S. W., Tuttle J. B., Trimmer P. A., Sheehan J. P., Bennett J. P., Davis R. E. and Parker W. D. (1996) Origin and funcional consequences of the complex I defect in Parkinson's disease. Ann. Neurol. 40, 663671.
  • Tabatabaie T., Potts J. and Floyd R. A. (1996) Reactive oxygen species-mediated inactivation of pyruvate dehydrogenase. Arch. Biochem. Biophys. 336, 290296.DOI: 10.1006/abbi.1996.0560
  • Zhang Y., Marcillat O., Giulivi C., Ernster L. and Davies K. J. (1990) The oxidative inactivation of mitochondrial electron transport chain components and ATPase. J. Biol. Chem. 265, 1633016336.
  • Ziegler D. M. (1985) Role of reversible oxidation-reduction of enzyme thiol–disulfides in metabolic regulation. Ann. Rev. Biochem. 54, 305329.